Breast Cancer Treatment Cost in Ahmedabad: What Patients and Families Need to Budget For

1. Diagnostic and Pre-Treatment Costs

Before surgery or systemic therapy begins, a series of investigations are required to confirm diagnosis, determine cancer type, and stage the disease accurately. These typically include:

• Mammography and breast ultrasound
• Core needle biopsy or excision biopsy with histopathology
• Hormone receptor and HER2 testing (immunohistochemistry)
• Blood investigations and tumour markers
• Staging scans — CT chest/abdomen/pelvis, bone scan, or PET-CT in advanced cases

In Ahmedabad, diagnostic costs for breast cancer can range broadly depending on the investigations required. PET-CT scans, in particular, represent a meaningful cost that families should anticipate when advanced staging is recommended.

2. Surgical Costs

Surgery is typically the primary treatment for breast cancer, and surgical costs form a substantial portion of the overall expense. Indicative ranges in Ahmedabad private cancer hospitals include:

• Lumpectomy (breast-conserving surgery): Generally a more cost-contained procedure with shorter hospital stay
• Simple or modified radical mastectomy: Higher surgical complexity; costs increase with operative time and post-operative care requirements
• Mastectomy with breast reconstruction: Involves additional surgical procedures (implant placement or flap reconstruction), which meaningfully increases the total cost
• Sentinel lymph node biopsy: Often performed alongside primary breast surgery; adds to surgical cost but reduces the need for full axillary dissection in eligible patients

Families should request a detailed surgical cost estimate from their treating hospital before the procedure, covering surgeon fees, anaesthesia, operation theatre charges, implants (if applicable), and hospital stay.

3. Chemotherapy Costs

Chemotherapy is recommended for many breast cancer patients — either before surgery (neoadjuvant chemotherapy) to shrink the tumour, or after surgery (adjuvant chemotherapy) to reduce recurrence risk. Chemotherapy costs depend on:

• The drug regimen prescribed (e.g., anthracycline-based, taxane-based, or combination protocols)
• The number of cycles required (typically 4–8 cycles)
• Whether targeted agents such as trastuzumab (Herceptin) are included for HER2-positive disease

Targeted therapy with trastuzumab, while highly effective for HER2-positive breast cancer, represents a significant cost consideration. Patients should discuss both branded and biosimilar options with their oncologist, as biosimilar versions approved for clinical use in India can offer meaningful cost savings without compromising treatment efficacy.

4. Radiation Therapy Costs

Radiation therapy is commonly recommended following lumpectomy to reduce the risk of local recurrence, and in some cases after mastectomy. The total cost of radiation depends on the technique used, the number of fractions (treatment sessions) prescribed, and the facility.

Modern radiation techniques such as intensity-modulated radiation therapy (IMRT) or 3D conformal radiotherapy offer precision in targeting tumour tissue while sparing surrounding healthy tissue — but may carry higher costs than conventional radiation approaches. Patients should clarify which technique is planned and what the full course of treatment will involve.

5. Hormone Therapy and Ongoing Medication Costs

For patients with hormone receptor-positive breast cancer, hormone therapy — typically with tamoxifen or aromatase inhibitors — is prescribed for five to ten years following primary treatment. These medications are generally among the more affordable components of long-term breast cancer management, though the cumulative cost over several years is worth factoring into family budgeting.

6. Follow-Up Care and Surveillance Costs

After completing primary treatment, patients enter a structured surveillance phase involving regular clinical examinations, annual mammography, and periodic blood tests. Follow-up care costs are often underestimated by families but represent an important ongoing investment in long-term health monitoring.